# Efficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell Transplant

> **NCT00597714** · PHASE2 · COMPLETED · sponsor: **David Rizzieri, MD** · enrollment: 264 (actual)

## Conditions studied

- Hodgkin's Disease
- Non Hodgkin's Lymphoma
- Myeloma
- Leukemia
- Myelodysplasia

## Interventions

- **DRUG:** Non-myeloablative Stem Cell Transplantation

## Key facts

- **NCT ID:** NCT00597714
- **Lead sponsor:** David Rizzieri, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2013-07
- **Final completion:** 2013-11
- **Target enrollment:** 264 (ACTUAL)
- **Last updated:** 2014-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00597714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00597714, "Efficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell Transplant". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00597714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*